Arbutus Biopharma and Roivant Sciences Sue Over Patents Related to Pfizer-BioNTech's COVID-19 Vaccine

Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), have filed three international lawsuits against Pfizer (PFE) and BioNTech (BNTX) over patent disputes related to their jointly developed COVID-19 vaccine. The suits were filed in Canada.

By Dulan Lokuwithana, SA News Editor · Seeking Alpha ·

Arbutus Biopharma and Roivant Sciences Sue Over Patents Related to Pfizer-BioNTech's COVID-19 Vaccine

Tickers: $ABUS $BNTX $PFE $ROIV

Topics: Biotech Lawsuits Pharmaceuticals Vaccines

Read the full article at Seeking Alpha

More World news